Menlo Park, California, USA
March 23, 2022
- Company Announces New European Headquarters to Serve Growing Customer Demand in Europe, Middle East and Africa Region
- Also Announces First Commercial Services Provider in Europe
PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate, sequencing platforms, today announced the company’s expansion to better serve customers in the Europe, Middle East and Africa (EMEA) region. The company announced a new European headquarters in London expected to open April 4, 2022, and a relationship with Swiss-based Genesupport, a Sonic Healthcare company, the first commercial service provider to offer PacBio sequencing services in Europe.
“As more European laboratories experience the power and accuracy of PacBio HiFi sequencing, there is a clear need to expand our footprint to match our investments in commercial support,” said Neil Ward, Vice President and General Manager of EMEA for PacBio. “In addition to our expansion, we are pleased to welcome Genesupport as our first European commercial service provider, helping us further extend the reach of PacBio HiFi sequencing in the region.”
The new PacBio EMEA headquarters is in the Rolling Stock Yard complex in London’s vibrant tech-centric Kings Cross neighborhood, making it easily accessible by train from London’s major airports and destinations across the United Kingdom and Europe. In addition to housing the PacBio EMEA commercial team, the site has extensive laboratory space which will be used for customer collaborations, training, and internal development projects.
As PacBio’s first European sequencing service provider, Genesupport will play a critical role in helping customers better access and understand the unique attributes of PacBio HiFi sequencing using PacBio Sequel IIe instruments. Under the name Fasteris, and as part of the Sonic Healthcare group of laboratories, Genesupport provides DNA services to researchers worldwide. Genesupport is also a leading medical genetics laboratory in Switzerland.
“As more studies illustrate the importance of long-read sequencing across genomics applications, it is clear that offering HiFi sequencing to our customers across EMEA will help us grow our business and offer PacBio’s advanced sequencing technology to researchers at the wide variety of laboratories we serve,” said Laurent Farinelli, Chief Executive Officer at Genesupport.
PacBio’s HiFi sequencing technology uniquely combines the benefits of high accuracy with long read lengths, providing a comprehensive view of genomes and transcriptomes to scientists tackling complex genetic challenges across many sequencing applications.
Topics
Species
